Deaths Associated with Human Adenovirus-14p1 Infections, Europe, 2009–2010Michael J. Carr, William W. Hall, Adriana E. Kajon et al.|Emerging infectious diseases|2011Cited by 75
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021Esther Kissling, Mariëtte Hooiveld, Virginia Martin et al.|Eurosurveillance|2021Cited by 55
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021Esther Kissling, Mariëtte Hooiveld, Iván Martínez‐Baz et al.|Eurosurveillance|2022Cited by 27
Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018–2019Angeliki Melidou, Natālija Zamjatina, Isabelle Thomas et al.|Vaccine|2020Cited by 13
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre study analysis by age-group, vaccine brand and time since vaccination, I-MOVE-COVID-19 and ECDC networks, July–August 2021Esther Kissling, Marta Valenciano, Mariëtte Hooiveld et al.|Unknown|2021Cited by 2